salmeterol xinafoate has been researched along with Epilepsy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budde, T; Cerina, M; Ehling, P; Kanyshkova, T; Meuth, P; Meuth, SG; Pape, HC; Zobeiri, M | 1 |
1 other study(ies) available for salmeterol xinafoate and Epilepsy
| Article | Year |
|---|---|
Regionally specific expression of high-voltage-activated calcium channels in thalamic nuclei of epileptic and non-epileptic rats.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Animals, Newborn; Biophysical Phenomena; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Electric Stimulation; Epilepsy; Immunosuppressive Agents; Membrane Potentials; Mutation Rate; Nerve Tissue Proteins; Neurons; Rats; Rats, Wistar; Salmeterol Xinafoate; Tacrolimus; Thalamic Nuclei; Up-Regulation | 2014 |